Literature DB >> 12510994

Eating disorders in females: genetics, pathophysiology, and treatment.

Katherine A Halmi1.   

Abstract

The eating disorders anorexia nervosa and bulimia nervosa are best conceptualized as syndromes and are classified on the basis of the clusters of symptoms they present. According to the multidimensional model, eating disorders begin with dieting, which is propelled into a full-blown disorder by antecedent conditions of biological vulnerability and genetics, premorbid psychological characteristics, family interactions, and social climate. The medical abnormalities present in individuals with eating disorders are due to starvation conditions and purging behaviors and will resolve with nutritional rehabilitation and the cessation of purging. Comorbid psychiatric conditions such as affective disorders, anxiety disorders, substance abuse, and personality disorders are frequently present. For anorexia nervosa, the most effective strategy is multidimensional treatment, consisting of nutritional rehabilitation, medical attention, individual cognitive psychotherapy, and family counseling or therapy if the patient is younger than age 18 years. For bulimia nervosa, the treatment of choice is cognitive-behavioral therapy with directions in a manual for therapists. A second choice for treatment is an antidepressant, beginning with fluoxetine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12510994

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  1 in total

1.  Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa.

Authors:  Timo Dirk Müller; Kathrin Reichwald; Günter Brönner; Jeanette Kirschner; Thuy Trang Nguyen; André Scherag; Wolfgang Herzog; Beate Herpertz-Dahlmann; Peter Lichtner; Thomas Meitinger; Matthias Platzer; Helmut Schäfer; Johannes Hebebrand; Anke Hinney
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2008-11-17       Impact factor: 3.033

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.